Effect of subdermal contraceptive implant (Implanon®) on biochemical
serum parameters
M.Inal, K. Ertopçu, M. Karacaer, M. Polat, S. Yetkin, Ö. Biçer, I.
Özelmas, Tinar
SSK (Social Security Agency) Aegean Maternity Hospital, Family Planning
Department, Izmir, Turkey
To evaluate the biochemical serum parameter changes in subdermal
contraceptive implant (Implanon®) users at the end of one year. Seventy women
who accepted subdermal contraceptive implant application for contraception were
enrolled into the study. Selected biochemical serum parameters before implant
insertion and at 12 months after implant insertion were tested. The biochemical
serum parameters evaluated were: Fasting blood glucose, blood urea nitrogen
(BUN), creatinine, SGOT, SGPT, low-density lipoprotein (LDL), high-density
lipoprotein (HDL), cholesterol, triglyceride. The statistical data were
evaluated by ttest. The mean age of the cases was 28.5 years. The mean number of
gravida was 2.5, mean number of parity was 1.6, mean number of abortions was
0.3, mean number of living children was 1.5. No statistical difference was
observed in between the initial and 12-months’ levels of fasting blood
glucose, BUN, SGOT, SGPT, LDL, HDL (p>0.05), but the increase in cholesterol
and triglyceride and the decrease in creatinine levels at the end of one year
was found to be statistically significant (p<0.05).
